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ABSTRACT
Aim To evaluate if broadening the criteria for
retinopathy of prematurity (ROP) screening to include
babies with gestational age ≥32 weeks and/or birth
weight ≥1500 g, would have an impact on the number
of babies diagnosed as having ROP.
Methods A prospective cohort study was carried out at
the Aga Khan University Hospital, Karachi, Pakistan.
Infants with gestational age ≤35 weeks or birth weight
≤2000 g born in this hospital from May 2010 to
December 2012 were screened for the presence of ROP
4–6 weeks after birth. Subsequent examinations were
performed at intervals based on the ﬁndings of initial
eye examinations. Infants diagnosed as having ROP were
treated with argon laser therapy. Neonatal risk factors
were also assessed. Cumulative incidence of ROP was
calculated for babies falling within and outside current
screening criteria. Multivariate logistic regression analysis
was performed to examine the predictors of ROP.
Results A total of 301 infants were screened: 27 (9%)
babies developed ROP, of which 19 had stage 3 ROP or
worse. None of the babies falling outside the current
screening criteria developed ROP. The incidence of ROP
in the infants meeting the current screening criteria was
11.5%. Multivariate logistic regression analysis showed
that only gestational age (adjusted relative risk 0.774,
95% CI 0.603 to 0.994) was independently associated
with the development of ROP.
Conclusions In our population ROP was not seen to
occur in infants older than 32 weeks gestational age
and/or weighing more than 1500 g.
INTRODUCTION
Retinopathy of prematurity (ROP) is a major avoid-
able cause of blindness in children.1 In developed
countries such as the USA, it is the second most
common cause of childhood blindness.2 Gilbert
et al3 suggest that heavier and more mature infants
are developing severe ROP in countries with low or
moderate levels of development compared with
developed countries. ROP is emerging as an
important cause of childhood blindness in develop-
ing countries because of signiﬁcant improvement in
survival rates of premature and low birthweight
infants. However, there is a lack of awareness of
the disease process and its screening criteria, com-
pounded by a lack of skilled human resources to
care for babies at risk of ROP.4
Research from several developing countries,
including India and China, has shown that the inter-
national screening criteria for ROP—gestational age
≤32 weeks and/or birth weight ≤1500 g—might not
be entirely applicable in this developing part of the
world.5 6 Babies as heavy as 2000 g at birth and as
mature as 35 weeks have been found to develop
ROP.6–8 Several investigators conclude that a signiﬁ-
cant proportion of ROP cases would have been
missed had they used the recommended screening
criteria, urging the need for development of region-
speciﬁc screening guidelines.9 Hence, we decided to
conduct a study to determine if broadening the cri-
teria for ROP screening would have an impact on
the number of babies diagnosed as having ROP.
METHODS
All infants—gestational age ≤35 weeks and birth
weight ≤2000 g—born at the Aga Khan University
Hospital (AKUH), Karachi, from May 2010 to
December 2012 were screened for the presence of
ROP. The study was approved by the Ethical
Review Committee of Aga Khan University,
Karachi. Informed consent was obtained from the
parents. Data were collected prospectively on gesta-
tional age, birth weight, postnatal age, neonatal ill-
nesses (eg, respiratory distress syndrome, sepsis and
apnoea) and treatment received (eg, supplemental
oxygen, phototherapy, blood transfusions and sur-
factant therapy).
All infants meeting the screening criteria were
scheduled for their ﬁrst examination between 4 and
6 weeks of life. Dilated fundus examinations were
carried out in the clinic or neonatal intensive care
unit (NICU) under topical anaesthesia by the con-
sultant ophthalmologist (TAC). Tropicamide (0.5%)
and phenylephrine (2.5%) eye drops were adminis-
tered three times, 15 min apart, before each exam-
ination. Binocular indirect ophthalmoscopy was
performed using a 20D and 30D lens. Lid specu-
lum and scleral depressors were used to ensure
adequate examination.
The ‘International Classiﬁcation of ROP’ guide-
lines were used to record stage of the disease, loca-
tion by zone, signs of plus disease and signs of
regression.10 Babies with no ROP were examined at
2-weekly intervals until they reached 40 weeks
post-conception age. Babies with stage 1 and 2
disease were followed up weekly to see if disease
regressed or if it progressed to stage 3, in which
case treatment was then offered. Infants with stage
3 ROP were treated with argon laser, with or
without intravitreal injections of bevacizumab,
within 72 h of diagnosis and followed weekly.
The termination of acute retinal screening exami-
nations was based on the latest guidelines by the
American Academy of Pediatrics (AAP), American
Academy of Ophthalmology and American
Association for Pediatric Ophthalmology and
Strabismus.5 All data was analysed using IBM SPSS
Statistics (V.19, SPSS Inc., an IBM company,
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Armonk, New York, USA). Data for gestational age and birth
weight for those who did and did not develop ROP were
expressed in the form of mean±SD values. Proportions were
calculated for categorical variables. The presence of risk factors
among those with and without ROP were tested for statistical
signiﬁcance using the χ2 test or univariate binary logistic regres-
sion. Independent variables that were associated with ROP with
p≤0.2 were included in the multivariate binary logistic regres-
sion to identify the independent predictors of ROP. A p value
< 0.05 was considered statistically signiﬁcant.
RESULTS
From April 2010 to December 2012, a total of 424 babies born
at the AKUH fulﬁlled the eligibility criteria and their parents
were invited to allow their participation in the study. Of these,
30 died while in the neonatal intensive care unit and 93 patients
did not attend the ﬁrst scheduled appointment. A total of 301
babies were examined; 163 (54.2%) were boys. The mean
(±SD) gestational age of study subjects was 31.2±2.3 weeks and
the mean birth weight was 1505±427 g (table 1). Overall, 9%
(27/301) babies were found to have ROP (table 2). Of 66
infants falling outside the current screening criteria (ie, GA
≤32 weeks & BW ≤1500 g), none developed ROP. Further ana-
lysis included only those infants who met the international
screening criteria for ROP (n=235). Overall, 11.5% (27/235)
babies developed ROP (table 3). Of those with ROP, 18 (66.7%)
had stage 3 and 1 had stage 4 disease. The mean number of
examinations was 2.06±1.47. Overall 93.7% babies were exam-
ined until they reached 40 weeks post-conception age or were
fully vascularised.
In the univariate analysis, factors signiﬁcantly associated with
ROP included birth weight, gestational age, supplemental
oxygen, surfactant therapy, septicaemia, birth apnoea, blood
transfusions and respiratory distress syndrome (table 4). Except
supplemental oxygen, all other predictors were included in the
multivariate analysis, which showed only gestational age as an
independent predictor of ROP (adjusted relative risk 0.774,
95% CI 0.603 to 0.994). All 19 babies with stage 3 ROP or
worse were treated, of whom 16 received laser and intravitreal
bevacizumab injection and 3 received laser treatment alone.
DISCUSSION
Contrary to the ﬁndings of several previous studies in low-
income countries, our study showed that none of the infants
falling outside the current screening criteria used across the
world (ie, gestational age ≤32 weeks and/or BW ≤1500 g) devel-
oped ROP.
Studies from India, China, Saudi Arabia and Turkey suggested
that a signiﬁcant proportion of babies requiring ROP treatment
might have been missed had they used a narrower screening cri-
terion.6 9 11–13 In light of such data, we decided to broaden our
screening criteria. However, of 66 infants (GA >32 weeks &
BW >1500 g) in our study, none developed ROP. It remains
unclear how many babies of this weight and age need to be
screened to detect one additional case of ROP and whether
these estimates would differ in different settings.
As part of our study, we also identiﬁed factors that could
increase the risk of such babies for developing ROP. Gestational
age emerged as independent risk factors for the development of
ROP. It is also important to mention that determination of
correct gestational age of a baby is also a signiﬁcant challenge in
Table 1 Demographic and clinical characteristics of newborn
babies enrolled in the study (n=301)
Characteristic Count %
Gender Male 163 54.2
Female 138 45.8
Total 301 100.0
Supplemental oxygen if given Yes 228 75.7
No 73 24.3
Surfactant Yes 71 23.6
No 230 76.4
Septicaemia Yes 80 26.6
No 221 73.4
Episode of birth apnoea Yes 57 18.9
No 244 81.1
Blood transfusions Yes 84 27.9
No 217 72.1
Phototherapy for neonatal jaundice Yes 214 71.1
No 87 28.9
Respiratory distress syndrome Yes 33 11.0
No 268 89.0
All values are reported as counts and percentages unless noted otherwise. Mean±SD
gestational age was 31.2±2.3 weeks, mean±SD birth weight was 1505±427 g.
Table 2 Risk of ROP among premature infants (gestational age
≤35 weeks and birth weight ≤2000 g) included in the study
(n=301)
Variable
Examined Infants with ROP
p Value*Count Count %
Overall 301 27 9.0
Gender 0.289
Male 163 12 7.4
Female 138 15 10.9
Supplemental oxygen 0.002
Yes 228 27 11.8
No 73 0 0
Surfactant <0.001
Yes 71 19 26.8
No 230 8 3.5
Septicaemia <0.001
Yes 80 15 18.8
No 221 12 5.4
Birth apnoea <0.001
Yes 57 13 22.8
No 244 14 5.7
Blood transfusions <0.001
Yes 84 21 25.0
No 217 6 2.8
Phototherapy 0.091
Yes 214 23 10.7
No 87 4 4.6
Respiratory distress syndrome 0.009
Yes 33 7 21.2
No 268 20 7.5
Meeting international screening
criteria
0.004
Yes 235 27 11.5
No 66 0 0.0
*p Values are for χ2 test (or Fisher’s exact test when necessary).
ROP, retinopathy of prematurity.
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developing countries especially among less educated. Incorrect
measure of GA may have resulted in misclassiﬁcation of risk in
this study as well as other studies.
The incidence of ROP in our study (11.5%) is much lower
than that reported in several previous studies. A possible explan-
ation for these variations, besides genetics, could be the relative
distribution of extremely premature babies and distribution of
ROP risk factors.
Threshold ROP (stage 3 or worse) was seen in 19 of the 27
babies (70.4%) who developed ROP. A study from India also
reported threshold disease in 62/138 (45%) babies.6
A limitation of our study was that it looked at ROP incidence
in just one hospital at a major Pakistan University with good
neonatal care. Things may be very different at smaller hospitals
in the country where neonatal care is not as advanced. Future
studies should include multiple high-volume centres to increase
generalisability. Patient compliance with regular follow-up exam-
inations was a limitation of our study. Reasons for low compli-
ance likely include lack of understanding of the seriousness of
ROP as well as the ﬁnancial constraints of the patients’ families.
Lack of appropriate counselling of parents by paediatricians/
neonatologists regarding the need for ophthalmic examination
in at-risk infants continues to be a factor for failure to have
their babies screened. Thus, we continue to see cases where
patients seek medical care only when the disease has reached an
irreversible stage with loss of red reﬂex and permanent loss of
vision.
Our current screening criteria adopted from the guidelines set
by the AAP, the American Association for Pediatric
Ophthalmology and Strabismus, and the American Academy of
Ophthalmology appear appropriate for the clinical setting of
ROP screening in Pakistan. However, a larger multicentre study
is needed to determine how many babies above this criterion
Table 3 Risk of ROP among premature infants with gestational
age ≤32 weeks and birth weight ≤1500 g (n=235)
Examined Infants with ROP
p Value*Count Count %
Overall 235 27 11.5
Gender 0.383
Male 123 12 9.8
Female 112 15 13.4
Supplemental oxygen 0.014
Yes 196 27 13.8
No 39 0 .0
Surfactant <0.001
Yes 67 19 28.4
No 168 8 4.8
Septicaemia <0.003
Yes 72 15 20.8
No 163 12 7.4
Birth apnoea <0.001
Yes 49 13 26.5
No 186 14 7.5
Blood transfusions <0.001
Yes 75 21 28.0
No 160 6 3.8
Phototherapy 0.135
Yes 172 23 13.4
No 63 4 6.3
Respiratory distress syndrome 0.006
Yes 25 7 28.0
No 210 20 9.5
*p Values are for χ2 test (or Fisher’s exact test when necessary).
ROP, retinopathy of prematurity.
Table 4 Univariate and multivariate analysis of factors associated with the risk of ROP among premature infants with gestational age
≤32 weeks and birth weight ≤1500 g (n=235)
Crude relative risk p Value Adjusted relative risk p Value
Birth weight 0.996 (0.994 to 0.998) <0.001 0.999 (0.996 to 1.001) 0.178
Gestational age 0.589 (0.501 to 0.691) <0.001 0.774 (0.603 to 0.994) 0.044
Surfactant <0.001 0.261
Yes 5.955 (2.607 to 13.603) 1.778 (0.651 to 4.854)
No 1.0 1.0
Septicaemia 0.007 0.668
Yes 2.830 (1.325 to 6.046) 1.206 (0.513 to 2.832)
No 1.0 1.0
Birth apnoea 0.001 0.209
Yes 3.525 (1.657 to 7.499) 1.723 (0.737 to 4.029)
No 1.0 1.0
Blood transfusions <0.001 0.349
Yes 7.467 (3.014 to 18.499) 1.757 (0.540 to 5.721)
No 1.0 1.0
Phototherapy 0.169 0.951
Yes 2.106 (0.728 to 6.090) 0.963 (0.292 to 3.183)
No 1.0 1.0
Respiratory distress syndrome 0.014 0.714
Yes 2.940 (1.243 to 6.953) 1.194 (0.464 to 3.071)
No 1.0 1.0
ROP, retinopathy of prematurity.
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need to be screened to detect one additional case of ROP and
how cost effective such a programme will be.
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